Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published January 3, 2020 | Accepted Version + Supplemental Material
Journal Article Open

Brain Region-Specific nAChR and Associated Protein Abundance Alterations Following Chronic Nicotine and/or Menthol Exposure

Abstract

The identification of biomarkers that are altered following nicotine/tobacco exposure can facilitate the investigation of tobacco-related diseases. Nicotinic acetylcholine receptors (nAChRs) are pentameric cation channels expressed in the mammalian central and peripheral nervous systems and the neuromuscular junction. Neuronal nAChR subunits (11) have been identified in mammals (α2-7, α9-10, β2-4). We examined changes in β2 nAChR subunit protein levels after chronic nicotine, (±)-menthol, or nicotine co-administered with (±)-menthol in nine murine brain regions. Our investigation of β2 nAChR subunit level changes identified the hypothalamus as a novel region of interest for menthol exposure that demonstrated increased β2 nAChR levels after (±)-menthol plus nicotine exposure compared to nicotine exposure alone. Using mass spectrometry, we further characterized changes in membrane protein abundance profiles in the hypothalamus to identify potential biomarkers of (±)-menthol plus nicotine exposure and proteins that may contribute to the elevated β2 nAChR subunit levels. In the hypothalamus, 272 membrane proteins were identified with altered abundances after chronic nicotine plus menthol exposure with respect to chronic nicotine exposure without menthol. A comprehensive investigation of changes in nAChR and non-nAChR protein expression resulting from (±)-menthol plus nicotine in the brain may establish biomarkers to better understand the effects of these drugs on addiction and addiction-related diseases.

Additional Information

© 2019 American Chemical Society. Received: April 30, 2019; Published: October 28, 2019. We also thank Dr. Steven P. Gygi and the Taplin Mass Spectrometry Facility at Harvard Medical School for use of their mass spectrometers and access to their Sequest-based data analysis suite. Author Contributions: The manuscript was written through the contributions of all authors. All authors have given approval to the final version of the manuscript. M.J.M., S.M.H., J.A.P., B.J.H., and H.A.L. conceived and designed experiments. M.J.M., S.M.H., and J.A.P. performed the experiments. J.A.P., J.H.W., and S.M. contributed reagents/materials/analysis tools. M.J.M. wrote the manuscript. M.J.M., S.M.H., J.A.P., B.J.H., and H.A.L. edited the manuscript. This research was supported by NIH R01DA036061 (H.A.L.) and R01GM132129 (J.A.P.). The authors declare no competing financial interest. The mass spectrometry proteomics data have been deposited to the PRIDE Archive (http://www.ebi.ac.uk/pride/archive/) via the PRIDE partner repository with the data set identifier PXD012244.(69)

Attached Files

Accepted Version - nihms-1595991.pdf

Supplemental Material - pr9b00286_si_001.xlsx

Files

nihms-1595991.pdf
Files (4.0 MB)
Name Size Download all
md5:29fa428e3cc44dfd4a1bdcd9cacd412f
2.7 MB Download
md5:6b4fc72f63484fef7790c0e848a57082
1.3 MB Preview Download

Additional details

Created:
August 19, 2023
Modified:
December 22, 2023